Dosing regimens associated with extended release paliperidone injectable formulations | Patent Number 11439647

US 11439647 B2
Application Number17314245
Publication NumberUS 20220168305 A1
Pendency1 year, 4 months, 9 days
Filled DateMay 7, 2021
Priority DateNov 30, 2020
Publication DateJun 2, 2022
Expiration DateNov 29, 2040
Inventor/ApplicantsJohn Louie
Ruth Milz
Frank Wiegand
Panna Sanga
ExaminesTHOMAS, TIMOTHY P
Art Unit1611
Technology Center1600
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Pharmaceuticals Johnson & JohnsonJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.